Search - tctmd.com

Displaying 101 - 120 of 129

Sort: Relevancy | Date

News Daily News

Self-Expanding Nitinol Stent Potential Option in Popliteal Artery Disease

January 24, 2013

News Industry News

CID Spa releases the NEXT Study 24-months data on its Cre8™ DES at TCT 2012

December 10, 2012

Presentation ICI 2012

A Unique Approach to Creating a Polymer Free Stent: The Medtronic Drug Filled Stent Program

Presenter: Josiah N. Wilcox

December 03, 2012

News Daily News

Zilver Stent Seen as Welcome Addition to PAD Armamentarium

L.A. McKeown

November 25, 2012

Presentation TCT 2012

Will Polymer-Free DES Be Safer Than Bare Metal Stents?

Presenter: Philip Urban

October 25, 2012

News Conference News TCT 2012

Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5

October 24, 2012

Presentation TCT 2012

TCT-48. Two Year Follow-up and Sub-group Analysis of a Polymer-free Sirolimus- and Probucol-eluting Stent vs. A New Generation Zotarolimus-eluting Stent in Coronary Artery Disease

Presenter: Lamin King

October 23, 2012

Presentation TCT 2012

TCT-46. Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 3-Year Results from the BioFreedom First-in-man Trial

Presenter: Eberhard Grube

October 23, 2012

News Daily News

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

Leah Lawrence

June 15, 2012

News Industry News

CID SpA Sponsors a Major Symposium at Euro PCR 2012

May 10, 2012

News Daily News

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

January 24, 2012

Presentation TCT 2012

The Nine-Month Outcomes of a Polymer-Free Drug-Eluting Stent (YUKON) Compared with Different Polymer Based Drug-Eluting Stents in Real-World Coronary Artery Lesions.

Presenter: Ted S. Trajceski, Lulzim Brovina, Zivko Petrovski, Blerim Zuna, Borce Petrovski

January 03, 2012

Presentation TCT 2012

First Report of A Novel Polymer-Free Dual-Drug Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man BICARE Trial

Presenter: Mengyue Yu, Bo Xu, Yongjian Wu, Hongbing Yan, Jue Chen, Jie Qian, Chaowei Mu, Fenghuan Hu, Weixian Yang, Shubin Qiao, Yuejin Yang, Run-Lin Gao

January 03, 2012

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

L.A. McKeown

November 28, 2011

News Conference News

Two New SES Show Improvement Over First-Generation Stents

Yael L. Maxwell

November 10, 2011

News Industry News

Polymer-free drug eluting stents result in lower in-stent late loss

November 10, 2011

News Conference News

Polymer-free DES Shown Effective in Multiple Trials

November 08, 2011

News Conference News

PAX Studies Highlight Polymer-Free DES Success

November 07, 2011

News Conference News

Evidence of Late Catch-up After DES ‘Unequivocal’

November 06, 2011

News Daily News

First DES for Above-the-Knee Vascular Disease on the Horizon

L.A. McKeown

October 18, 2011

Advertisement

Self-Expanding Nitinol Stent Potential Option in Popliteal Artery Disease

CID Spa releases the NEXT Study 24-months data on its Cre8™ DES at TCT 2012

A Unique Approach to Creating a Polymer Free Stent: The Medtronic Drug Filled Stent Program

Zilver Stent Seen as Welcome Addition to PAD Armamentarium

Will Polymer-Free DES Be Safer Than Bare Metal Stents?

Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5

TCT-48. Two Year Follow-up and Sub-group Analysis of a Polymer-free Sirolimus- and Probucol-eluting Stent vs. A New Generation Zotarolimus-eluting Stent in Coronary Artery Disease

TCT-46. Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 3-Year Results from the BioFreedom First-in-man Trial

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

CID SpA Sponsors a Major Symposium at Euro PCR 2012

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

The Nine-Month Outcomes of a Polymer-Free Drug-Eluting Stent (YUKON) Compared with Different Polymer Based Drug-Eluting Stents in Real-World Coronary Artery Lesions.

First Report of A Novel Polymer-Free Dual-Drug Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man BICARE Trial

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

Two New SES Show Improvement Over First-Generation Stents

Polymer-free drug eluting stents result in lower in-stent late loss

Polymer-free DES Shown Effective in Multiple Trials

PAX Studies Highlight Polymer-Free DES Success

Evidence of Late Catch-up After DES ‘Unequivocal’

First DES for Above-the-Knee Vascular Disease on the Horizon

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content